| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Embryonic Stem Cells | 85 | 2020 | 1263 | 10.380 |
Why?
|
| Pluripotent Stem Cells | 65 | 2024 | 799 | 9.520 |
Why?
|
| Hematopoietic Stem Cells | 96 | 2023 | 3396 | 8.980 |
Why?
|
| Induced Pluripotent Stem Cells | 80 | 2023 | 1860 | 8.180 |
Why?
|
| RNA-Binding Proteins | 40 | 2024 | 1897 | 6.570 |
Why?
|
| Hematopoiesis | 50 | 2022 | 2049 | 4.460 |
Why?
|
| Cell Differentiation | 131 | 2024 | 11528 | 4.380 |
Why?
|
| Embryo, Mammalian | 38 | 2022 | 1675 | 4.190 |
Why?
|
| Stem Cell Research | 10 | 2022 | 37 | 3.990 |
Why?
|
| Stem Cells | 36 | 2021 | 3522 | 3.120 |
Why?
|
| Fusion Proteins, bcr-abl | 34 | 2016 | 431 | 3.090 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 32 | 2016 | 686 | 3.030 |
Why?
|
| Stem Cell Transplantation | 26 | 2019 | 1600 | 2.860 |
Why?
|
| Homeodomain Proteins | 35 | 2021 | 2416 | 2.250 |
Why?
|
| Cell Lineage | 34 | 2022 | 2555 | 2.100 |
Why?
|
| MicroRNAs | 33 | 2024 | 3816 | 2.080 |
Why?
|
| Cell Culture Techniques | 23 | 2015 | 1667 | 1.950 |
Why?
|
| Hematologic Diseases | 6 | 2015 | 496 | 1.710 |
Why?
|
| Regenerative Medicine | 10 | 2017 | 306 | 1.670 |
Why?
|
| Embryo Research | 6 | 2019 | 38 | 1.640 |
Why?
|
| Animals | 251 | 2024 | 168459 | 1.620 |
Why?
|
| Genetic Diseases, Inborn | 6 | 2024 | 604 | 1.620 |
Why?
|
| Mice | 186 | 2024 | 81525 | 1.540 |
Why?
|
| DNA-Binding Proteins | 33 | 2020 | 9606 | 1.540 |
Why?
|
| Transcription Factors | 39 | 2021 | 12128 | 1.490 |
Why?
|
| Gene Expression Regulation, Developmental | 27 | 2021 | 3612 | 1.400 |
Why?
|
| Protein-Tyrosine Kinases | 14 | 2018 | 2425 | 1.370 |
Why?
|
| Embryonic Development | 14 | 2021 | 721 | 1.330 |
Why?
|
| Systems Biology | 5 | 2019 | 481 | 1.330 |
Why?
|
| Germ Cells | 9 | 2019 | 634 | 1.290 |
Why?
|
| Fibroblasts | 27 | 2016 | 4141 | 1.280 |
Why?
|
| HMGA2 Protein | 3 | 2020 | 102 | 1.280 |
Why?
|
| Multipotent Stem Cells | 6 | 2022 | 200 | 1.170 |
Why?
|
| Cell Line | 61 | 2017 | 15601 | 1.150 |
Why?
|
| Signal Transduction | 48 | 2021 | 23445 | 1.140 |
Why?
|
| Octamer Transcription Factor-3 | 12 | 2014 | 223 | 1.130 |
Why?
|
| Trophoblasts | 4 | 2017 | 224 | 1.100 |
Why?
|
| Blastocyst | 11 | 2013 | 433 | 1.090 |
Why?
|
| Zebrafish | 22 | 2022 | 3007 | 1.080 |
Why?
|
| Genes, abl | 11 | 2009 | 69 | 1.070 |
Why?
|
| Morphogenesis | 2 | 2021 | 741 | 1.060 |
Why?
|
| Cell Separation | 16 | 2013 | 1720 | 1.060 |
Why?
|
| Retroviridae | 14 | 2012 | 850 | 0.930 |
Why?
|
| Epigenesis, Genetic | 20 | 2015 | 3802 | 0.920 |
Why?
|
| Bioethical Issues | 3 | 2021 | 120 | 0.900 |
Why?
|
| Bone Marrow Diseases | 4 | 2013 | 233 | 0.880 |
Why?
|
| Drug Discovery | 4 | 2019 | 1051 | 0.870 |
Why?
|
| Piperazines | 15 | 2010 | 2523 | 0.870 |
Why?
|
| Pyrimidines | 15 | 2010 | 3028 | 0.860 |
Why?
|
| Leukemia | 7 | 2019 | 1522 | 0.840 |
Why?
|
| Neuroblastoma | 3 | 2021 | 1250 | 0.830 |
Why?
|
| Teratoma | 7 | 2013 | 404 | 0.830 |
Why?
|
| Nuclear Transfer Techniques | 10 | 2013 | 61 | 0.830 |
Why?
|
| Fanconi Anemia | 4 | 2020 | 324 | 0.820 |
Why?
|
| Erythropoiesis | 5 | 2020 | 683 | 0.820 |
Why?
|
| Lipomatosis | 2 | 2013 | 112 | 0.810 |
Why?
|
| Exocrine Pancreatic Insufficiency | 2 | 2013 | 86 | 0.810 |
Why?
|
| Guidelines as Topic | 4 | 2016 | 1386 | 0.800 |
Why?
|
| Cell Transformation, Neoplastic | 17 | 2011 | 2825 | 0.800 |
Why?
|
| Humans | 270 | 2024 | 761504 | 0.790 |
Why?
|
| Palpation | 1 | 2022 | 166 | 0.780 |
Why?
|
| Cells, Cultured | 47 | 2020 | 18965 | 0.770 |
Why?
|
| RNA Interference | 12 | 2016 | 2831 | 0.770 |
Why?
|
| Anniversaries and Special Events | 1 | 2022 | 95 | 0.760 |
Why?
|
| Chimera | 6 | 2019 | 453 | 0.760 |
Why?
|
| Cell Dedifferentiation | 4 | 2015 | 122 | 0.750 |
Why?
|
| Gene Expression Regulation | 24 | 2019 | 11903 | 0.740 |
Why?
|
| Oocytes | 7 | 2013 | 1166 | 0.740 |
Why?
|
| Toes | 1 | 2022 | 209 | 0.730 |
Why?
|
| Wnt Proteins | 4 | 2015 | 718 | 0.720 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 17 | 2017 | 5671 | 0.690 |
Why?
|
| Ethics Committees, Clinical | 1 | 2020 | 56 | 0.690 |
Why?
|
| Dyskeratosis Congenita | 2 | 2011 | 73 | 0.690 |
Why?
|
| Anemia, Diamond-Blackfan | 2 | 2020 | 138 | 0.690 |
Why?
|
| Cell Proliferation | 25 | 2019 | 10445 | 0.680 |
Why?
|
| Totipotent Stem Cells | 2 | 2013 | 16 | 0.670 |
Why?
|
| Societies, Scientific | 5 | 2022 | 222 | 0.660 |
Why?
|
| Models, Biological | 22 | 2021 | 9469 | 0.660 |
Why?
|
| Parthenogenesis | 3 | 2007 | 30 | 0.650 |
Why?
|
| Benzamides | 15 | 2010 | 1370 | 0.640 |
Why?
|
| Drug Resistance, Neoplasm | 13 | 2021 | 5305 | 0.630 |
Why?
|
| Ectoderm | 2 | 2009 | 137 | 0.630 |
Why?
|
| Bone Morphogenetic Proteins | 4 | 2015 | 842 | 0.630 |
Why?
|
| Ribosomes | 1 | 2021 | 501 | 0.610 |
Why?
|
| DNA Methylation | 16 | 2015 | 4398 | 0.600 |
Why?
|
| Transgenes | 6 | 2012 | 1010 | 0.600 |
Why?
|
| Pancreas | 3 | 2013 | 1691 | 0.590 |
Why?
|
| Ventilators, Mechanical | 1 | 2020 | 288 | 0.590 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 8 | 2020 | 359 | 0.590 |
Why?
|
| Gene Expression Regulation, Leukemic | 5 | 2019 | 651 | 0.580 |
Why?
|
| Genes, Homeobox | 5 | 2012 | 285 | 0.580 |
Why?
|
| Bone Marrow Transplantation | 9 | 2015 | 2693 | 0.570 |
Why?
|
| Gene Knockdown Techniques | 6 | 2021 | 1612 | 0.560 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2021 | 2748 | 0.560 |
Why?
|
| Gene Regulatory Networks | 7 | 2022 | 1745 | 0.550 |
Why?
|
| Disease | 3 | 2012 | 672 | 0.550 |
Why?
|
| Receptors, CCR5 | 1 | 2019 | 486 | 0.540 |
Why?
|
| Health Care Rationing | 1 | 2020 | 437 | 0.540 |
Why?
|
| Proto-Oncogene Proteins | 13 | 2017 | 4511 | 0.540 |
Why?
|
| Trans-Activators | 7 | 2020 | 2856 | 0.530 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2015 | 484 | 0.520 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2016 | 113 | 0.520 |
Why?
|
| Farnesyltranstransferase | 6 | 2007 | 71 | 0.520 |
Why?
|
| Mesonephros | 5 | 2022 | 42 | 0.510 |
Why?
|
| Acetyl Coenzyme A | 2 | 2015 | 74 | 0.510 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2016 | 112 | 0.510 |
Why?
|
| Anemia, Sickle Cell | 1 | 2024 | 1063 | 0.500 |
Why?
|
| Gene Expression | 14 | 2018 | 7581 | 0.500 |
Why?
|
| Lymphocytes | 5 | 2021 | 2612 | 0.500 |
Why?
|
| Alternative Splicing | 2 | 2018 | 1093 | 0.500 |
Why?
|
| Mice, Knockout | 26 | 2024 | 14414 | 0.500 |
Why?
|
| Spleen | 8 | 2014 | 2295 | 0.500 |
Why?
|
| Antigens, CD34 | 5 | 2019 | 658 | 0.500 |
Why?
|
| Government Regulation | 4 | 2019 | 524 | 0.490 |
Why?
|
| Gametogenesis | 3 | 2017 | 26 | 0.490 |
Why?
|
| Acids | 1 | 2015 | 125 | 0.490 |
Why?
|
| Valine | 1 | 2016 | 408 | 0.490 |
Why?
|
| Receptor, Notch1 | 2 | 2015 | 496 | 0.480 |
Why?
|
| Transduction, Genetic | 7 | 2009 | 903 | 0.480 |
Why?
|
| Neoplastic Stem Cells | 5 | 2011 | 1347 | 0.480 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 16 | 2015 | 4575 | 0.480 |
Why?
|
| Oral Health | 1 | 2020 | 492 | 0.470 |
Why?
|
| Genetic Vectors | 11 | 2017 | 3395 | 0.470 |
Why?
|
| G2 Phase | 1 | 2014 | 136 | 0.470 |
Why?
|
| Regeneration | 7 | 2015 | 1511 | 0.470 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 5 | 2013 | 1136 | 0.460 |
Why?
|
| Endothelium | 2 | 2017 | 765 | 0.460 |
Why?
|
| Telomere | 2 | 2011 | 943 | 0.460 |
Why?
|
| Flow Cytometry | 19 | 2019 | 5869 | 0.460 |
Why?
|
| Autophagy | 3 | 2017 | 1326 | 0.450 |
Why?
|
| Transfection | 13 | 2015 | 5774 | 0.450 |
Why?
|
| Spermatozoa | 3 | 2007 | 630 | 0.450 |
Why?
|
| Mice, Transgenic | 14 | 2019 | 9539 | 0.450 |
Why?
|
| Glucose | 6 | 2015 | 4346 | 0.440 |
Why?
|
| Endothelium, Vascular | 7 | 2020 | 4431 | 0.440 |
Why?
|
| Hedgehog Proteins | 2 | 2021 | 768 | 0.440 |
Why?
|
| Zebrafish Proteins | 8 | 2021 | 1014 | 0.430 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2015 | 502 | 0.430 |
Why?
|
| Histones | 6 | 2017 | 2580 | 0.430 |
Why?
|
| Sexual Maturation | 2 | 2015 | 261 | 0.420 |
Why?
|
| Triage | 1 | 2020 | 986 | 0.420 |
Why?
|
| Glycolysis | 3 | 2022 | 835 | 0.420 |
Why?
|
| Cell Division | 14 | 2014 | 4465 | 0.420 |
Why?
|
| Gene Amplification | 2 | 2016 | 1089 | 0.420 |
Why?
|
| RNA, Messenger | 17 | 2021 | 12795 | 0.420 |
Why?
|
| Receptors, Notch | 3 | 2016 | 743 | 0.420 |
Why?
|
| Fanconi Anemia Complementation Group A Protein | 3 | 2020 | 50 | 0.410 |
Why?
|
| Neoplasm Metastasis | 3 | 2021 | 4915 | 0.410 |
Why?
|
| Nobel Prize | 1 | 2012 | 48 | 0.410 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2019 | 1606 | 0.410 |
Why?
|
| Proto-Oncogene Proteins c-abl | 3 | 2009 | 140 | 0.410 |
Why?
|
| Tissue Engineering | 3 | 2019 | 1868 | 0.410 |
Why?
|
| Adaptive Immunity | 2 | 2016 | 726 | 0.400 |
Why?
|
| Physiology | 1 | 2012 | 111 | 0.400 |
Why?
|
| Small Molecule Libraries | 2 | 2018 | 733 | 0.400 |
Why?
|
| Oncogene Proteins | 1 | 2016 | 718 | 0.400 |
Why?
|
| Mice, Inbred C57BL | 24 | 2022 | 22169 | 0.400 |
Why?
|
| Internationality | 2 | 2016 | 1001 | 0.400 |
Why?
|
| Keratinocytes | 3 | 2014 | 790 | 0.400 |
Why?
|
| MAP Kinase Signaling System | 2 | 2016 | 1486 | 0.400 |
Why?
|
| Single-Cell Analysis | 5 | 2021 | 2449 | 0.400 |
Why?
|
| Wound Healing | 3 | 2013 | 2805 | 0.390 |
Why?
|
| Receptors, Cytokine | 3 | 2004 | 258 | 0.390 |
Why?
|
| Threonine | 2 | 2012 | 271 | 0.390 |
Why?
|
| Gene Transfer Techniques | 3 | 2006 | 1206 | 0.390 |
Why?
|
| Milk Proteins | 2 | 2003 | 163 | 0.390 |
Why?
|
| Interferon-alpha | 1 | 2016 | 921 | 0.390 |
Why?
|
| Gene Silencing | 2 | 2018 | 1509 | 0.390 |
Why?
|
| Protein Kinase Inhibitors | 7 | 2021 | 5671 | 0.390 |
Why?
|
| Hematopoietic System | 3 | 2010 | 110 | 0.390 |
Why?
|
| Hemoglobinopathies | 1 | 2012 | 99 | 0.380 |
Why?
|
| Gene Expression Regulation, Neoplastic | 15 | 2024 | 8547 | 0.380 |
Why?
|
| Bone Marrow Cells | 8 | 2010 | 2416 | 0.370 |
Why?
|
| Chromatin | 6 | 2020 | 2960 | 0.370 |
Why?
|
| Diffusion of Innovation | 1 | 2016 | 728 | 0.370 |
Why?
|
| Wilms Tumor | 1 | 2014 | 379 | 0.370 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2014 | 655 | 0.370 |
Why?
|
| Philadelphia Chromosome | 6 | 2016 | 117 | 0.370 |
Why?
|
| Tissue Scaffolds | 2 | 2017 | 934 | 0.370 |
Why?
|
| Repressor Proteins | 8 | 2017 | 2986 | 0.370 |
Why?
|
| Communicable Diseases | 1 | 2019 | 875 | 0.360 |
Why?
|
| Proto-Oncogene Proteins c-myc | 7 | 2014 | 988 | 0.360 |
Why?
|
| Adult Stem Cells | 3 | 2013 | 221 | 0.360 |
Why?
|
| Lentivirus | 3 | 2009 | 508 | 0.360 |
Why?
|
| Kruppel-Like Transcription Factors | 4 | 2012 | 504 | 0.360 |
Why?
|
| Enzyme Inhibitors | 5 | 2007 | 3712 | 0.350 |
Why?
|
| src-Family Kinases | 3 | 2009 | 535 | 0.350 |
Why?
|
| Piperidines | 6 | 2007 | 1656 | 0.350 |
Why?
|
| Antineoplastic Agents | 13 | 2016 | 13639 | 0.350 |
Why?
|
| Cloning, Organism | 4 | 2005 | 50 | 0.350 |
Why?
|
| Chromosomes, Human, Pair 17 | 3 | 2008 | 418 | 0.340 |
Why?
|
| Fertilization in Vitro | 3 | 2019 | 1292 | 0.340 |
Why?
|
| Models, Genetic | 6 | 2016 | 3442 | 0.340 |
Why?
|
| Life | 1 | 2009 | 13 | 0.340 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2014 | 736 | 0.330 |
Why?
|
| Mutation | 22 | 2021 | 30052 | 0.330 |
Why?
|
| Alkyl and Aryl Transferases | 4 | 2003 | 86 | 0.330 |
Why?
|
| Interferon Regulatory Factors | 2 | 2009 | 261 | 0.330 |
Why?
|
| Homeostasis | 3 | 2017 | 3323 | 0.330 |
Why?
|
| Integrases | 1 | 2012 | 516 | 0.330 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 1 | 2010 | 146 | 0.330 |
Why?
|
| Transcription, Genetic | 8 | 2016 | 7594 | 0.330 |
Why?
|
| Blood Cells | 2 | 2009 | 305 | 0.330 |
Why?
|
| Mutagenesis, Insertional | 1 | 2012 | 656 | 0.320 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2009 | 121 | 0.320 |
Why?
|
| Policy | 3 | 2022 | 508 | 0.320 |
Why?
|
| Hemangioblasts | 2 | 2021 | 28 | 0.320 |
Why?
|
| Stromal Cells | 6 | 2019 | 1330 | 0.310 |
Why?
|
| RNA Processing, Post-Transcriptional | 4 | 2018 | 416 | 0.310 |
Why?
|
| Embryo Culture Techniques | 3 | 2017 | 84 | 0.310 |
Why?
|
| Pyridines | 7 | 2007 | 2875 | 0.310 |
Why?
|
| Placenta | 2 | 2015 | 1709 | 0.310 |
Why?
|
| Blastocyst Inner Cell Mass | 1 | 2008 | 7 | 0.310 |
Why?
|
| Cell Fusion | 2 | 2010 | 294 | 0.310 |
Why?
|
| Education, Medical | 1 | 2020 | 1725 | 0.310 |
Why?
|
| Fertility | 1 | 2013 | 771 | 0.310 |
Why?
|
| Recombination, Genetic | 3 | 2007 | 1519 | 0.300 |
Why?
|
| Yolk Sac | 2 | 2012 | 79 | 0.300 |
Why?
|
| Gene Targeting | 4 | 2017 | 838 | 0.300 |
Why?
|
| RNA | 3 | 2013 | 2726 | 0.300 |
Why?
|
| Work | 1 | 2009 | 195 | 0.300 |
Why?
|
| HMGB Proteins | 1 | 2007 | 45 | 0.300 |
Why?
|
| Cytidine Deaminase | 1 | 2010 | 243 | 0.300 |
Why?
|
| Tretinoin | 4 | 2012 | 519 | 0.300 |
Why?
|
| Point Mutation | 4 | 2011 | 1595 | 0.300 |
Why?
|
| Chemokines, CC | 1 | 2009 | 283 | 0.300 |
Why?
|
| Nuclear Proteins | 7 | 2016 | 5796 | 0.290 |
Why?
|
| Promoter Regions, Genetic | 8 | 2014 | 5789 | 0.290 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 1616 | 0.290 |
Why?
|
| Fetal Blood | 2 | 2011 | 1347 | 0.290 |
Why?
|
| Body Size | 1 | 2010 | 463 | 0.280 |
Why?
|
| Trypsin | 1 | 2008 | 495 | 0.280 |
Why?
|
| Biology | 1 | 2009 | 290 | 0.280 |
Why?
|
| Cyclins | 3 | 2014 | 594 | 0.280 |
Why?
|
| Oogenesis | 2 | 2007 | 124 | 0.280 |
Why?
|
| Biotechnology | 2 | 2015 | 282 | 0.270 |
Why?
|
| Gene Expression Profiling | 16 | 2016 | 9420 | 0.270 |
Why?
|
| Mesoderm | 7 | 2011 | 674 | 0.270 |
Why?
|
| Trisomy | 1 | 2008 | 260 | 0.270 |
Why?
|
| Clinical Trials as Topic | 6 | 2016 | 8002 | 0.270 |
Why?
|
| Kidney | 4 | 2019 | 7048 | 0.270 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2008 | 430 | 0.270 |
Why?
|
| Biomedical Technology | 1 | 2008 | 211 | 0.270 |
Why?
|
| H-2 Antigens | 1 | 2006 | 357 | 0.270 |
Why?
|
| Animals, Newborn | 3 | 2019 | 2678 | 0.270 |
Why?
|
| Disease Models, Animal | 17 | 2022 | 18252 | 0.270 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2011 | 1974 | 0.270 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2008 | 641 | 0.260 |
Why?
|
| Green Fluorescent Proteins | 7 | 2020 | 2065 | 0.260 |
Why?
|
| Heterozygote | 3 | 2007 | 2787 | 0.260 |
Why?
|
| Informed Consent | 4 | 2016 | 1008 | 0.260 |
Why?
|
| Mice, Inbred BALB C | 11 | 2013 | 6216 | 0.260 |
Why?
|
| Huntington Disease | 3 | 2023 | 1144 | 0.260 |
Why?
|
| Histocompatibility | 1 | 2006 | 317 | 0.250 |
Why?
|
| Uridine | 2 | 2018 | 141 | 0.250 |
Why?
|
| Heterochromatin | 2 | 2021 | 293 | 0.250 |
Why?
|
| Graft Survival | 3 | 2014 | 3819 | 0.250 |
Why?
|
| Polymerase Chain Reaction | 4 | 2012 | 6075 | 0.240 |
Why?
|
| Erythrocytes | 3 | 2019 | 2413 | 0.240 |
Why?
|
| Antigens, CD | 3 | 2015 | 4003 | 0.240 |
Why?
|
| Myeloid Cells | 3 | 2015 | 823 | 0.240 |
Why?
|
| Cell Nucleolus | 2 | 2024 | 156 | 0.240 |
Why?
|
| Neoplasms | 10 | 2019 | 22170 | 0.240 |
Why?
|
| Interferon Type I | 1 | 2009 | 562 | 0.240 |
Why?
|
| Leukemia, Experimental | 6 | 2001 | 225 | 0.240 |
Why?
|
| Models, Animal | 5 | 2019 | 2112 | 0.240 |
Why?
|
| Targeted Gene Repair | 2 | 2015 | 20 | 0.240 |
Why?
|
| Blotting, Western | 8 | 2016 | 5035 | 0.230 |
Why?
|
| Female | 51 | 2021 | 392644 | 0.230 |
Why?
|
| Histone-Lysine N-Methyltransferase | 4 | 2019 | 682 | 0.230 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2009 | 491 | 0.230 |
Why?
|
| HeLa Cells | 6 | 2020 | 3093 | 0.230 |
Why?
|
| Adenine | 1 | 2009 | 987 | 0.230 |
Why?
|
| Stress, Mechanical | 1 | 2009 | 1674 | 0.230 |
Why?
|
| bcl-X Protein | 4 | 2011 | 410 | 0.230 |
Why?
|
| Major Histocompatibility Complex | 1 | 2006 | 870 | 0.230 |
Why?
|
| Hematologic Agents | 1 | 2024 | 40 | 0.230 |
Why?
|
| RNA, Ribosomal | 2 | 2021 | 227 | 0.230 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2007 | 1693 | 0.220 |
Why?
|
| Dinoprostone | 3 | 2015 | 597 | 0.220 |
Why?
|
| Endogenous Retroviruses | 2 | 2015 | 111 | 0.220 |
Why?
|
| Cell Cycle | 5 | 2016 | 2932 | 0.220 |
Why?
|
| Public Policy | 2 | 2005 | 559 | 0.220 |
Why?
|
| Preimplantation Diagnosis | 2 | 2019 | 143 | 0.220 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2010 | 1844 | 0.220 |
Why?
|
| RNA, Small Interfering | 8 | 2016 | 3429 | 0.220 |
Why?
|
| Interleukin-3 | 5 | 2005 | 425 | 0.210 |
Why?
|
| Methylation | 3 | 2016 | 1084 | 0.210 |
Why?
|
| Neoplasm Proteins | 6 | 2006 | 3617 | 0.210 |
Why?
|
| Cell Cycle Proteins | 6 | 2020 | 3448 | 0.210 |
Why?
|
| Lung | 1 | 2021 | 10000 | 0.210 |
Why?
|
| Hepatocytes | 2 | 2013 | 1233 | 0.210 |
Why?
|
| Transplantation, Autologous | 5 | 2017 | 2115 | 0.210 |
Why?
|
| Practice Guidelines as Topic | 4 | 2021 | 7390 | 0.210 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2022 | 3613 | 0.210 |
Why?
|
| Bone Marrow | 7 | 2022 | 2911 | 0.200 |
Why?
|
| Cell Survival | 11 | 2014 | 5791 | 0.200 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3084 | 0.200 |
Why?
|
| Adipocytes | 1 | 2009 | 1194 | 0.200 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3204 | 0.200 |
Why?
|
| Physicians | 1 | 2020 | 4591 | 0.200 |
Why?
|
| Oocyte Donation | 2 | 2016 | 52 | 0.200 |
Why?
|
| Liver | 4 | 2014 | 7529 | 0.200 |
Why?
|
| Leukopoiesis | 1 | 2001 | 54 | 0.200 |
Why?
|
| Endoderm | 3 | 2012 | 160 | 0.200 |
Why?
|
| Fibroblast Growth Factor 10 | 1 | 2021 | 31 | 0.190 |
Why?
|
| Tumor Cells, Cultured | 6 | 2007 | 6132 | 0.190 |
Why?
|
| Cytogenetic Analysis | 2 | 2016 | 270 | 0.190 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2011 | 3734 | 0.190 |
Why?
|
| Fetal Hemoglobin | 1 | 2024 | 345 | 0.190 |
Why?
|
| Genes, Reporter | 3 | 2020 | 1529 | 0.190 |
Why?
|
| Adaptation, Physiological | 1 | 2008 | 1301 | 0.190 |
Why?
|
| Research Embryo Creation | 3 | 2005 | 8 | 0.190 |
Why?
|
| Thrombospondins | 1 | 2001 | 193 | 0.190 |
Why?
|
| Genetic Complementation Test | 2 | 2017 | 554 | 0.190 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2010 | 11742 | 0.190 |
Why?
|
| DNA Mutational Analysis | 3 | 2011 | 4111 | 0.180 |
Why?
|
| Luminescent Proteins | 3 | 2014 | 837 | 0.180 |
Why?
|
| Binding Sites | 7 | 2020 | 6055 | 0.180 |
Why?
|
| Cell Transformation, Viral | 2 | 2001 | 526 | 0.180 |
Why?
|
| Fluorescent Antibody Technique | 4 | 2014 | 2469 | 0.180 |
Why?
|
| Embryo, Nonmammalian | 7 | 2021 | 906 | 0.180 |
Why?
|
| Cell Line, Tumor | 12 | 2021 | 16981 | 0.180 |
Why?
|
| Feedback, Physiological | 2 | 2021 | 476 | 0.180 |
Why?
|
| Cell Transplantation | 3 | 2011 | 472 | 0.180 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2008 | 1745 | 0.180 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2014 | 3778 | 0.180 |
Why?
|
| History, 20th Century | 3 | 2016 | 2767 | 0.180 |
Why?
|
| Thrombopoietin | 1 | 2003 | 226 | 0.180 |
Why?
|
| Genetic Association Studies | 1 | 2010 | 2735 | 0.180 |
Why?
|
| SOX9 Transcription Factor | 1 | 2021 | 145 | 0.180 |
Why?
|
| Protein Structure, Tertiary | 6 | 2010 | 3792 | 0.180 |
Why?
|
| Globins | 2 | 2017 | 404 | 0.180 |
Why?
|
| Hybrid Cells | 2 | 2014 | 422 | 0.180 |
Why?
|
| RNA 3' End Processing | 1 | 2020 | 16 | 0.180 |
Why?
|
| Erythroid Precursor Cells | 2 | 2016 | 211 | 0.170 |
Why?
|
| Drug Resistance | 1 | 2006 | 1596 | 0.170 |
Why?
|
| Oncogene Protein pp60(v-src) | 1 | 1999 | 75 | 0.170 |
Why?
|
| Genomics | 3 | 2015 | 5821 | 0.170 |
Why?
|
| Pandemics | 1 | 2020 | 8654 | 0.170 |
Why?
|
| Cytosine | 2 | 2011 | 211 | 0.170 |
Why?
|
| Colony-Forming Units Assay | 4 | 2014 | 352 | 0.170 |
Why?
|
| Genome | 4 | 2011 | 1740 | 0.170 |
Why?
|
| T-Lymphocytes | 3 | 2022 | 10194 | 0.170 |
Why?
|
| Receptors, Erythropoietin | 1 | 1999 | 144 | 0.170 |
Why?
|
| Aging | 4 | 2022 | 8708 | 0.170 |
Why?
|
| DNA, Recombinant | 1 | 2020 | 455 | 0.160 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2011 | 15936 | 0.160 |
Why?
|
| Spermatogenesis | 2 | 2013 | 259 | 0.160 |
Why?
|
| Epidermolysis Bullosa | 1 | 2019 | 29 | 0.160 |
Why?
|
| Fetus | 3 | 2013 | 1863 | 0.160 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2022 | 1551 | 0.160 |
Why?
|
| Antigens, Ly | 1 | 2020 | 295 | 0.160 |
Why?
|
| Cell Nucleus | 6 | 2009 | 2909 | 0.160 |
Why?
|
| Immunoprecipitation | 3 | 2016 | 878 | 0.160 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2015 | 1334 | 0.160 |
Why?
|
| Genomic Imprinting | 2 | 2015 | 329 | 0.160 |
Why?
|
| Oxidative Phosphorylation | 3 | 2016 | 496 | 0.160 |
Why?
|
| Tissue Transplantation | 1 | 2019 | 128 | 0.160 |
Why?
|
| Adenocarcinoma | 2 | 2015 | 6346 | 0.160 |
Why?
|
| Genome, Human | 6 | 2016 | 4425 | 0.160 |
Why?
|
| Lymphoid Tissue | 2 | 1998 | 445 | 0.160 |
Why?
|
| Proteoglycans | 2 | 2016 | 803 | 0.160 |
Why?
|
| Oncogenes | 8 | 2014 | 1222 | 0.160 |
Why?
|
| Sequence Analysis, DNA | 5 | 2011 | 4740 | 0.160 |
Why?
|
| Meiosis | 3 | 2006 | 328 | 0.150 |
Why?
|
| Male | 40 | 2020 | 360804 | 0.150 |
Why?
|
| Alleles | 6 | 2022 | 6863 | 0.150 |
Why?
|
| Chemokine CCL5 | 1 | 2019 | 214 | 0.150 |
Why?
|
| Blast Crisis | 3 | 1996 | 102 | 0.150 |
Why?
|
| Macrophages | 5 | 2023 | 5769 | 0.150 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2022 | 800 | 0.150 |
Why?
|
| Mice, Inbred CBA | 2 | 2010 | 436 | 0.150 |
Why?
|
| Medically Underserved Area | 1 | 2020 | 254 | 0.150 |
Why?
|
| Genes, Synthetic | 1 | 1998 | 88 | 0.150 |
Why?
|
| Germ Layers | 2 | 2012 | 72 | 0.150 |
Why?
|
| Protein Binding | 9 | 2020 | 9351 | 0.150 |
Why?
|
| Resource Allocation | 1 | 2020 | 350 | 0.150 |
Why?
|
| Transplantation, Heterologous | 3 | 2019 | 2385 | 0.140 |
Why?
|
| Mycobacterium Infections | 1 | 1998 | 122 | 0.140 |
Why?
|
| Epigenomics | 3 | 2012 | 943 | 0.140 |
Why?
|
| Motor Neurons | 2 | 2013 | 870 | 0.140 |
Why?
|
| Allyl Compounds | 1 | 2017 | 22 | 0.140 |
Why?
|
| K562 Cells | 4 | 2009 | 642 | 0.140 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2019 | 269 | 0.140 |
Why?
|
| Kidney Neoplasms | 1 | 2014 | 4249 | 0.140 |
Why?
|
| Twins | 1 | 2019 | 339 | 0.140 |
Why?
|
| Aorta | 3 | 2020 | 2042 | 0.140 |
Why?
|
| Organoids | 2 | 2023 | 740 | 0.140 |
Why?
|
| Reproductive Techniques | 1 | 2017 | 41 | 0.140 |
Why?
|
| Cell Transdifferentiation | 2 | 2015 | 185 | 0.140 |
Why?
|
| Antigens, Surface | 4 | 2006 | 1606 | 0.140 |
Why?
|
| Apoptosis | 9 | 2020 | 9486 | 0.140 |
Why?
|
| Clone Cells | 4 | 2009 | 1659 | 0.140 |
Why?
|
| Mutagenesis | 3 | 2011 | 1232 | 0.140 |
Why?
|
| Kidney Function Tests | 1 | 2019 | 678 | 0.140 |
Why?
|
| Proteins | 6 | 2011 | 6032 | 0.140 |
Why?
|
| Neurons | 10 | 2013 | 9463 | 0.130 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2012 | 2872 | 0.130 |
Why?
|
| Interleukin-8 | 2 | 2016 | 695 | 0.130 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1998 | 226 | 0.130 |
Why?
|
| Enzyme Activation | 3 | 2014 | 3597 | 0.130 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2019 | 267 | 0.130 |
Why?
|
| HEK293 Cells | 3 | 2021 | 4278 | 0.130 |
Why?
|
| Transforming Growth Factor beta | 2 | 2016 | 1961 | 0.130 |
Why?
|
| ras Proteins | 1 | 2001 | 1054 | 0.130 |
Why?
|
| Molecular Biology | 1 | 2000 | 576 | 0.130 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2019 | 305 | 0.130 |
Why?
|
| Karyotyping | 4 | 2012 | 1171 | 0.130 |
Why?
|
| Phenotype | 8 | 2015 | 16591 | 0.130 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2024 | 2298 | 0.130 |
Why?
|
| Myocytes, Cardiac | 4 | 2013 | 1668 | 0.130 |
Why?
|
| Neoplasm Invasiveness | 3 | 2015 | 3595 | 0.130 |
Why?
|
| Mice, Mutant Strains | 2 | 2015 | 1749 | 0.130 |
Why?
|
| Withholding Treatment | 1 | 2020 | 617 | 0.130 |
Why?
|
| Antigens, Differentiation | 2 | 2016 | 910 | 0.130 |
Why?
|
| Consumer Product Safety | 1 | 2016 | 122 | 0.130 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 2015 | 64 | 0.130 |
Why?
|
| Models, Molecular | 5 | 2018 | 5439 | 0.130 |
Why?
|
| Telomerase | 2 | 2011 | 745 | 0.130 |
Why?
|
| Leukemia, Mast-Cell | 1 | 2015 | 13 | 0.120 |
Why?
|
| Receptor, Adenosine A2B | 1 | 2015 | 34 | 0.120 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2022 | 1349 | 0.120 |
Why?
|
| Cardiovascular System | 1 | 2003 | 834 | 0.120 |
Why?
|
| Inflammasomes | 1 | 2020 | 526 | 0.120 |
Why?
|
| Erythroid Cells | 1 | 2017 | 238 | 0.120 |
Why?
|
| DNA, Complementary | 5 | 2009 | 1991 | 0.120 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2016 | 302 | 0.120 |
Why?
|
| Colorectal Neoplasms | 1 | 2015 | 6935 | 0.120 |
Why?
|
| Proteome | 3 | 2016 | 1862 | 0.120 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2015 | 89 | 0.120 |
Why?
|
| Protein Conformation | 4 | 2009 | 3968 | 0.120 |
Why?
|
| History, 21st Century | 2 | 2012 | 1567 | 0.120 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2020 | 529 | 0.120 |
Why?
|
| Time Factors | 13 | 2016 | 39967 | 0.120 |
Why?
|
| Protein Stability | 1 | 2016 | 578 | 0.120 |
Why?
|
| STAT1 Transcription Factor | 1 | 2016 | 341 | 0.120 |
Why?
|
| B-Lymphocytes | 4 | 2019 | 4758 | 0.120 |
Why?
|
| Deoxyribonucleases | 2 | 2013 | 211 | 0.120 |
Why?
|
| Proviruses | 2 | 2015 | 313 | 0.120 |
Why?
|
| Genes, Neoplasm | 1 | 2016 | 370 | 0.120 |
Why?
|
| Computational Biology | 3 | 2019 | 3518 | 0.120 |
Why?
|
| Up-Regulation | 4 | 2012 | 4124 | 0.120 |
Why?
|
| Gonads | 1 | 2014 | 109 | 0.120 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2016 | 412 | 0.110 |
Why?
|
| Prescription Fees | 1 | 2015 | 153 | 0.110 |
Why?
|
| Receptors, Calcitriol | 1 | 2016 | 360 | 0.110 |
Why?
|
| 3' Untranslated Regions | 1 | 2016 | 519 | 0.110 |
Why?
|
| Immunohistochemistry | 8 | 2015 | 11076 | 0.110 |
Why?
|
| In Situ Hybridization | 3 | 2012 | 1900 | 0.110 |
Why?
|
| Cell Line, Transformed | 4 | 2008 | 867 | 0.110 |
Why?
|
| Metabolome | 3 | 2010 | 989 | 0.110 |
Why?
|
| Hepatoblastoma | 1 | 2014 | 90 | 0.110 |
Why?
|
| Heart | 2 | 2011 | 4404 | 0.110 |
Why?
|
| Mice, 129 Strain | 1 | 2014 | 371 | 0.110 |
Why?
|
| Congresses as Topic | 1 | 2019 | 803 | 0.110 |
Why?
|
| Cell Movement | 6 | 2020 | 5203 | 0.110 |
Why?
|
| CDC2 Protein Kinase | 1 | 2014 | 213 | 0.110 |
Why?
|
| Phosphorylation | 5 | 2016 | 8320 | 0.110 |
Why?
|
| Nucleotides | 1 | 2016 | 454 | 0.110 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2020 | 2917 | 0.110 |
Why?
|
| Viral Proteins | 2 | 2013 | 1804 | 0.110 |
Why?
|
| Growth and Development | 1 | 2013 | 47 | 0.110 |
Why?
|
| Translocation, Genetic | 2 | 2003 | 1393 | 0.110 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2014 | 189 | 0.110 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2020 | 946 | 0.110 |
Why?
|
| Species Specificity | 3 | 2012 | 2414 | 0.110 |
Why?
|
| Oncogene Proteins v-abl | 2 | 1992 | 19 | 0.110 |
Why?
|
| Mastocytosis, Systemic | 1 | 2015 | 103 | 0.110 |
Why?
|
| Stem Cell Niche | 1 | 2016 | 345 | 0.110 |
Why?
|
| Neoplasm Transplantation | 4 | 2001 | 2016 | 0.110 |
Why?
|
| Progeria | 1 | 2015 | 188 | 0.110 |
Why?
|
| G1 Phase | 1 | 2014 | 403 | 0.110 |
Why?
|
| Blood Platelets | 2 | 2019 | 2479 | 0.110 |
Why?
|
| Mammals | 1 | 2019 | 1132 | 0.110 |
Why?
|
| Coculture Techniques | 4 | 2012 | 1341 | 0.110 |
Why?
|
| Endothelial Cells | 4 | 2021 | 3548 | 0.110 |
Why?
|
| Pregnancy | 6 | 2016 | 29874 | 0.110 |
Why?
|
| DNA | 7 | 2011 | 7212 | 0.110 |
Why?
|
| Patient Advocacy | 1 | 2015 | 360 | 0.110 |
Why?
|
| SOXB1 Transcription Factors | 3 | 2010 | 286 | 0.110 |
Why?
|
| Retinal Degeneration | 1 | 2017 | 413 | 0.110 |
Why?
|
| Methyltransferases | 2 | 2015 | 377 | 0.110 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2013 | 171 | 0.100 |
Why?
|
| Euchromatin | 1 | 2012 | 54 | 0.100 |
Why?
|
| Liver Neoplasms | 2 | 2024 | 4320 | 0.100 |
Why?
|
| China | 1 | 2019 | 2369 | 0.100 |
Why?
|
| Down Syndrome | 2 | 2012 | 901 | 0.100 |
Why?
|
| Carbon | 1 | 2016 | 666 | 0.100 |
Why?
|
| Phosphoproteins | 1 | 2021 | 2448 | 0.100 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2013 | 186 | 0.100 |
Why?
|
| Nodal Signaling Ligands | 1 | 2012 | 12 | 0.100 |
Why?
|
| Leukemia, Myeloid | 4 | 2010 | 694 | 0.100 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2022 | 1469 | 0.100 |
Why?
|
| Myristic Acids | 1 | 1992 | 49 | 0.100 |
Why?
|
| Dwarfism | 1 | 2013 | 138 | 0.100 |
Why?
|
| Sequence Analysis, RNA | 2 | 2018 | 2020 | 0.100 |
Why?
|
| Microarray Analysis | 2 | 2014 | 749 | 0.100 |
Why?
|
| Cyclic AMP | 2 | 2015 | 1463 | 0.100 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2012 | 98 | 0.100 |
Why?
|
| TDP-43 Proteinopathies | 1 | 2012 | 38 | 0.100 |
Why?
|
| Immunity, Cellular | 1 | 1998 | 1560 | 0.100 |
Why?
|
| Gene Deletion | 3 | 2016 | 2665 | 0.100 |
Why?
|
| Genotype | 6 | 2012 | 12990 | 0.100 |
Why?
|
| YY1 Transcription Factor | 1 | 2012 | 60 | 0.100 |
Why?
|
| Membrane Proteins | 5 | 2020 | 7856 | 0.100 |
Why?
|
| Microscopy, Confocal | 2 | 2015 | 1971 | 0.100 |
Why?
|
| Cytokines | 3 | 2005 | 7396 | 0.100 |
Why?
|
| United States | 9 | 2020 | 72334 | 0.100 |
Why?
|
| STAT5 Transcription Factor | 2 | 2003 | 265 | 0.100 |
Why?
|
| Amino Acid Sequence | 4 | 2016 | 13446 | 0.100 |
Why?
|
| Platelet Transfusion | 1 | 2014 | 297 | 0.100 |
Why?
|
| Central Nervous System | 2 | 2012 | 1336 | 0.100 |
Why?
|
| Hair Follicle | 1 | 2013 | 211 | 0.100 |
Why?
|
| Virus Activation | 1 | 2013 | 322 | 0.100 |
Why?
|
| Mass Spectrometry | 2 | 2016 | 2192 | 0.100 |
Why?
|
| Macular Degeneration | 1 | 2019 | 1007 | 0.100 |
Why?
|
| Chromosome Deletion | 1 | 2016 | 1386 | 0.100 |
Why?
|
| Ribonucleoproteins | 1 | 2014 | 372 | 0.090 |
Why?
|
| CpG Islands | 3 | 2012 | 1230 | 0.090 |
Why?
|
| Drug Design | 2 | 2009 | 1048 | 0.090 |
Why?
|
| Androgens | 1 | 1999 | 1286 | 0.090 |
Why?
|
| S-Adenosylmethionine | 1 | 2012 | 218 | 0.090 |
Why?
|
| Doxycycline | 3 | 2005 | 344 | 0.090 |
Why?
|
| Transformation, Genetic | 2 | 2001 | 192 | 0.090 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2022 | 4580 | 0.090 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2015 | 1062 | 0.090 |
Why?
|
| Nerve Tissue | 1 | 2011 | 78 | 0.090 |
Why?
|
| Multigene Family | 2 | 2012 | 1076 | 0.090 |
Why?
|
| Adaptation, Biological | 1 | 2011 | 147 | 0.090 |
Why?
|
| Retinoblastoma Protein | 1 | 2014 | 672 | 0.090 |
Why?
|
| Transcriptional Activation | 3 | 2008 | 1756 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2011 | 169 | 0.090 |
Why?
|
| Cadherins | 1 | 2015 | 903 | 0.090 |
Why?
|
| Muscle Development | 1 | 2012 | 259 | 0.090 |
Why?
|
| Rats | 8 | 2022 | 23742 | 0.090 |
Why?
|
| International Cooperation | 2 | 2007 | 1422 | 0.090 |
Why?
|
| I-kappa B Kinase | 1 | 2012 | 250 | 0.090 |
Why?
|
| Adipogenesis | 2 | 2012 | 368 | 0.090 |
Why?
|
| GATA6 Transcription Factor | 1 | 2010 | 50 | 0.090 |
Why?
|
| Mice, SCID | 4 | 2020 | 2626 | 0.090 |
Why?
|
| Quinazolines | 1 | 2017 | 1371 | 0.090 |
Why?
|
| Biological Assay | 2 | 2012 | 626 | 0.090 |
Why?
|
| Immunophenotyping | 2 | 2007 | 1870 | 0.090 |
Why?
|
| Photoreceptor Cells | 1 | 2011 | 236 | 0.090 |
Why?
|
| History, 19th Century | 1 | 2012 | 720 | 0.090 |
Why?
|
| Cell Shape | 2 | 2009 | 371 | 0.090 |
Why?
|
| Adenosine | 1 | 2015 | 808 | 0.090 |
Why?
|
| Base Sequence | 10 | 2014 | 12441 | 0.090 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 2231 | 0.090 |
Why?
|
| Muscle Proteins | 2 | 2020 | 1154 | 0.090 |
Why?
|
| Infertility | 1 | 2017 | 654 | 0.090 |
Why?
|
| Peptide Hydrolases | 1 | 2013 | 624 | 0.090 |
Why?
|
| Recombinant Proteins | 3 | 2020 | 6534 | 0.090 |
Why?
|
| Homozygote | 2 | 2007 | 1776 | 0.090 |
Why?
|
| Chromosome Aberrations | 2 | 2009 | 1768 | 0.090 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2012 | 1642 | 0.090 |
Why?
|
| Growth | 1 | 2011 | 365 | 0.080 |
Why?
|
| Inhibitory Concentration 50 | 3 | 2010 | 465 | 0.080 |
Why?
|
| Erythrocyte Transfusion | 1 | 2014 | 565 | 0.080 |
Why?
|
| GATA4 Transcription Factor | 1 | 2010 | 124 | 0.080 |
Why?
|
| Testis | 1 | 2013 | 794 | 0.080 |
Why?
|
| Endothelium-Dependent Relaxing Factors | 1 | 2009 | 21 | 0.080 |
Why?
|
| Tetracycline | 2 | 2002 | 216 | 0.080 |
Why?
|
| Interferon-gamma | 1 | 1998 | 3162 | 0.080 |
Why?
|
| Sequence Deletion | 2 | 2013 | 1494 | 0.080 |
Why?
|
| Organelles | 1 | 2011 | 266 | 0.080 |
Why?
|
| Mitochondrial Diseases | 1 | 2013 | 343 | 0.080 |
Why?
|
| Protease Inhibitors | 1 | 2013 | 754 | 0.080 |
Why?
|
| NF-kappa B | 2 | 2015 | 2490 | 0.080 |
Why?
|
| Adrenoleukodystrophy | 1 | 2011 | 143 | 0.080 |
Why?
|
| Genetic Engineering | 1 | 2015 | 933 | 0.080 |
Why?
|
| Tail | 1 | 2009 | 91 | 0.080 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2020 | 1727 | 0.080 |
Why?
|
| Immunologic Deficiency Syndromes | 2 | 2010 | 547 | 0.080 |
Why?
|
| Consensus | 1 | 2019 | 3123 | 0.080 |
Why?
|
| Epoxy Compounds | 1 | 2009 | 137 | 0.080 |
Why?
|
| Clinical Trials Data Monitoring Committees | 1 | 2008 | 25 | 0.080 |
Why?
|
| Fellowships and Scholarships | 1 | 2017 | 1117 | 0.080 |
Why?
|
| Fragile X Syndrome | 1 | 2010 | 116 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2015 | 17904 | 0.080 |
Why?
|
| Neural Crest | 1 | 2011 | 279 | 0.080 |
Why?
|
| Spheroids, Cellular | 1 | 2010 | 330 | 0.080 |
Why?
|
| Body Patterning | 3 | 2011 | 632 | 0.080 |
Why?
|
| Receptor Cross-Talk | 1 | 2009 | 116 | 0.080 |
Why?
|
| Organ Specificity | 2 | 2012 | 1967 | 0.080 |
Why?
|
| Stem Cell Factor | 2 | 2013 | 195 | 0.080 |
Why?
|
| Tetracycline Resistance | 2 | 1998 | 22 | 0.080 |
Why?
|
| Japan | 1 | 2012 | 1378 | 0.080 |
Why?
|
| Butadienes | 1 | 2008 | 107 | 0.080 |
Why?
|
| Inositol | 1 | 2009 | 215 | 0.080 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2017 | 1070 | 0.080 |
Why?
|
| Urothelium | 1 | 2010 | 269 | 0.080 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2008 | 178 | 0.080 |
Why?
|
| Extremities | 1 | 2013 | 867 | 0.080 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2012 | 699 | 0.080 |
Why?
|
| DNA, Mitochondrial | 1 | 2013 | 865 | 0.070 |
Why?
|
| Myocardium | 1 | 2001 | 4726 | 0.070 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 3602 | 0.070 |
Why?
|
| Tumor Suppressor Protein p14ARF | 3 | 2002 | 84 | 0.070 |
Why?
|
| Molecular Sequence Data | 7 | 2014 | 17635 | 0.070 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2011 | 727 | 0.070 |
Why?
|
| Information Dissemination | 1 | 2016 | 1126 | 0.070 |
Why?
|
| Mast Cells | 1 | 2015 | 1392 | 0.070 |
Why?
|
| DNA Primers | 3 | 2014 | 2819 | 0.070 |
Why?
|
| Research | 1 | 2016 | 1982 | 0.070 |
Why?
|
| Stress, Physiological | 1 | 2015 | 1403 | 0.070 |
Why?
|
| Protein Prenylation | 1 | 2007 | 70 | 0.070 |
Why?
|
| Hemoglobins | 1 | 2013 | 1525 | 0.070 |
Why?
|
| Haploidy | 2 | 2006 | 126 | 0.070 |
Why?
|
| Nonmuscle Myosin Type IIA | 1 | 2007 | 28 | 0.070 |
Why?
|
| Staining and Labeling | 1 | 2011 | 1085 | 0.070 |
Why?
|
| Platelet Membrane Glycoprotein IIb | 1 | 2007 | 51 | 0.070 |
Why?
|
| Interleukin-6 | 3 | 2004 | 3208 | 0.070 |
Why?
|
| Algorithms | 3 | 2019 | 14031 | 0.070 |
Why?
|
| Drug Costs | 1 | 2015 | 1183 | 0.070 |
Why?
|
| Cardiomyopathies | 1 | 2019 | 1964 | 0.070 |
Why?
|
| Genomic Instability | 2 | 2008 | 709 | 0.070 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2008 | 398 | 0.070 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 8529 | 0.070 |
Why?
|
| T-Box Domain Proteins | 3 | 2011 | 469 | 0.070 |
Why?
|
| RNA, Untranslated | 1 | 2010 | 459 | 0.070 |
Why?
|
| Tissue Banks | 1 | 2008 | 184 | 0.070 |
Why?
|
| Herpesvirus 1, Human | 1 | 2012 | 753 | 0.070 |
Why?
|
| Health Care Costs | 1 | 2020 | 3242 | 0.070 |
Why?
|
| Peer Review | 1 | 2008 | 217 | 0.070 |
Why?
|
| Leukemia Inhibitory Factor | 2 | 2004 | 77 | 0.070 |
Why?
|
| Mice, Inbred NOD | 2 | 2020 | 1827 | 0.070 |
Why?
|
| Crystallography, X-Ray | 2 | 2008 | 1990 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2004 | 1405 | 0.070 |
Why?
|
| Osteogenesis | 2 | 2012 | 1273 | 0.070 |
Why?
|
| Patient Participation | 1 | 2015 | 1444 | 0.070 |
Why?
|
| Cell Aggregation | 2 | 2003 | 239 | 0.070 |
Why?
|
| Thorax | 1 | 2009 | 555 | 0.070 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2012 | 1493 | 0.070 |
Why?
|
| Purines | 1 | 2009 | 607 | 0.070 |
Why?
|
| Vertebrates | 1 | 2007 | 227 | 0.070 |
Why?
|
| Myeloproliferative Disorders | 2 | 2008 | 613 | 0.060 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 3877 | 0.060 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1987 | 340 | 0.060 |
Why?
|
| Oligonucleotides | 1 | 2009 | 582 | 0.060 |
Why?
|
| Chromosome Segregation | 1 | 2006 | 235 | 0.060 |
Why?
|
| Energy Metabolism | 2 | 2013 | 2882 | 0.060 |
Why?
|
| Eye Diseases | 1 | 2011 | 653 | 0.060 |
Why?
|
| Protein Subunits | 2 | 2011 | 943 | 0.060 |
Why?
|
| Wedge Argument | 1 | 2005 | 6 | 0.060 |
Why?
|
| Thrombopoiesis | 1 | 2007 | 165 | 0.060 |
Why?
|
| Polymorphism, Genetic | 3 | 2001 | 4243 | 0.060 |
Why?
|
| Beginning of Human Life | 1 | 2005 | 9 | 0.060 |
Why?
|
| Nerve Regeneration | 1 | 2011 | 795 | 0.060 |
Why?
|
| Glycoprotein Hormones, alpha Subunit | 1 | 2005 | 95 | 0.060 |
Why?
|
| Blotting, Southern | 1 | 2005 | 777 | 0.060 |
Why?
|
| Sex Characteristics | 1 | 2015 | 2639 | 0.060 |
Why?
|
| Histocompatibility Testing | 1 | 2007 | 712 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 1171 | 0.060 |
Why?
|
| Protein Biosynthesis | 2 | 2024 | 2113 | 0.060 |
Why?
|
| Central Nervous System Infections | 1 | 2005 | 61 | 0.060 |
Why?
|
| Kinetics | 6 | 2016 | 6374 | 0.060 |
Why?
|
| RNA, Viral | 1 | 2013 | 2846 | 0.060 |
Why?
|
| Personhood | 1 | 2005 | 31 | 0.060 |
Why?
|
| Flavonoids | 1 | 2008 | 445 | 0.060 |
Why?
|
| Immunoblotting | 2 | 2011 | 1646 | 0.060 |
Why?
|
| Body Weight | 1 | 2015 | 4618 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2012 | 1934 | 0.060 |
Why?
|
| Prognosis | 3 | 2016 | 29625 | 0.060 |
Why?
|
| Nervous System Diseases | 2 | 2014 | 1666 | 0.060 |
Why?
|
| Embryo Disposition | 1 | 2004 | 14 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2005 | 314 | 0.060 |
Why?
|
| Efficiency | 1 | 2008 | 476 | 0.060 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 2811 | 0.060 |
Why?
|
| Thiazoles | 2 | 2009 | 1517 | 0.060 |
Why?
|
| Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2004 | 30 | 0.060 |
Why?
|
| Receptors, OSM-LIF | 1 | 2004 | 15 | 0.060 |
Why?
|
| Regulon | 1 | 2024 | 71 | 0.060 |
Why?
|
| Cell Adhesion | 3 | 2011 | 3087 | 0.060 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2004 | 66 | 0.060 |
Why?
|
| Amino Acid Substitution | 2 | 2012 | 1738 | 0.060 |
Why?
|
| Terminology as Topic | 1 | 2011 | 1530 | 0.060 |
Why?
|
| Cell Count | 1 | 2008 | 1835 | 0.060 |
Why?
|
| Interferons | 2 | 2012 | 706 | 0.060 |
Why?
|
| Mitochondria | 1 | 2017 | 3624 | 0.060 |
Why?
|
| Thrombocytosis | 1 | 2004 | 89 | 0.060 |
Why?
|
| Age Factors | 3 | 2019 | 18395 | 0.050 |
Why?
|
| Insulin-Secreting Cells | 1 | 2011 | 901 | 0.050 |
Why?
|
| Tibia | 1 | 2009 | 1070 | 0.050 |
Why?
|
| Adult | 12 | 2022 | 221177 | 0.050 |
Why?
|
| Europe | 2 | 2013 | 3422 | 0.050 |
Why?
|
| Genes, gag | 1 | 2002 | 55 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2007 | 727 | 0.050 |
Why?
|
| Nitriles | 1 | 2008 | 971 | 0.050 |
Why?
|
| Moloney murine leukemia virus | 1 | 2002 | 109 | 0.050 |
Why?
|
| Fertilization | 1 | 2003 | 199 | 0.050 |
Why?
|
| Femur | 1 | 2009 | 1307 | 0.050 |
Why?
|
| Genes, myc | 2 | 2016 | 390 | 0.050 |
Why?
|
| Vitamin D | 1 | 2016 | 3303 | 0.050 |
Why?
|
| Liver Regeneration | 1 | 2004 | 213 | 0.050 |
Why?
|
| Specimen Handling | 1 | 2007 | 702 | 0.050 |
Why?
|
| Microfilament Proteins | 2 | 2012 | 1134 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 2020 | 5368 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2004 | 522 | 0.050 |
Why?
|
| Benzhydryl Compounds | 1 | 2009 | 916 | 0.050 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2006 | 1435 | 0.050 |
Why?
|
| Polycythemia Vera | 1 | 2004 | 161 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2004 | 435 | 0.050 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2013 | 1469 | 0.050 |
Why?
|
| Spine | 1 | 2009 | 1118 | 0.050 |
Why?
|
| Therapeutics | 1 | 2002 | 113 | 0.050 |
Why?
|
| Amoeba | 1 | 1982 | 20 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 3 | 2012 | 1069 | 0.050 |
Why?
|
| Abelson murine leukemia virus | 4 | 1991 | 41 | 0.050 |
Why?
|
| DNA Damage | 3 | 2013 | 2446 | 0.050 |
Why?
|
| Embryonic Induction | 1 | 2002 | 151 | 0.050 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2001 | 61 | 0.050 |
Why?
|
| Coronary Artery Disease | 1 | 2001 | 6403 | 0.050 |
Why?
|
| Cyclin D2 | 1 | 2002 | 98 | 0.050 |
Why?
|
| Ethics, Research | 1 | 2003 | 176 | 0.050 |
Why?
|
| Molecular Structure | 1 | 2006 | 1880 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-pim-1 | 1 | 2001 | 32 | 0.050 |
Why?
|
| Serum Albumin | 1 | 2005 | 672 | 0.050 |
Why?
|
| Radiation Chimera | 1 | 2001 | 216 | 0.050 |
Why?
|
| Ovarian Follicle | 1 | 2003 | 244 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2009 | 20098 | 0.050 |
Why?
|
| Dictyostelium | 1 | 1982 | 70 | 0.050 |
Why?
|
| Receptors, Thrombopoietin | 1 | 2003 | 160 | 0.050 |
Why?
|
| Transcription Initiation Site | 2 | 2012 | 188 | 0.050 |
Why?
|
| Federal Government | 1 | 2003 | 267 | 0.050 |
Why?
|
| Software | 1 | 2015 | 4434 | 0.050 |
Why?
|
| Cluster Analysis | 3 | 2016 | 2707 | 0.050 |
Why?
|
| Lymphopoiesis | 1 | 2022 | 133 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 1 | 2002 | 420 | 0.050 |
Why?
|
| Treatment Failure | 2 | 2007 | 2645 | 0.050 |
Why?
|
| Zygote | 1 | 2021 | 115 | 0.050 |
Why?
|
| Monitoring, Physiologic | 1 | 2008 | 1779 | 0.050 |
Why?
|
| Contractile Proteins | 1 | 1982 | 240 | 0.050 |
Why?
|
| Financing, Government | 1 | 2004 | 472 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2009 | 4615 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2001 | 11460 | 0.040 |
Why?
|
| 5-Methylcytosine | 2 | 2011 | 148 | 0.040 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2001 | 276 | 0.040 |
Why?
|
| Genetic Loci | 3 | 2017 | 2632 | 0.040 |
Why?
|
| Computer Simulation | 3 | 2009 | 6240 | 0.040 |
Why?
|
| Chemotaxis | 2 | 1999 | 598 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2016 | 546 | 0.040 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2005 | 497 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2009 | 2135 | 0.040 |
Why?
|
| Retina | 1 | 2011 | 2659 | 0.040 |
Why?
|
| Antibodies | 2 | 2011 | 2418 | 0.040 |
Why?
|
| Thrombospondin 1 | 1 | 2001 | 257 | 0.040 |
Why?
|
| Spodoptera | 1 | 2020 | 141 | 0.040 |
Why?
|
| DNA, Neoplasm | 3 | 2006 | 1745 | 0.040 |
Why?
|
| Research Support as Topic | 1 | 2004 | 697 | 0.040 |
Why?
|
| Models, Anatomic | 1 | 2004 | 683 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 2003 | 1229 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2006 | 1989 | 0.040 |
Why?
|
| Calmodulin | 1 | 2020 | 218 | 0.040 |
Why?
|
| Megakaryocytes | 2 | 2019 | 566 | 0.040 |
Why?
|
| Central Nervous System Diseases | 1 | 2004 | 520 | 0.040 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2002 | 227 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 1 | 2004 | 871 | 0.040 |
Why?
|
| Muscular Diseases | 2 | 2014 | 553 | 0.040 |
Why?
|
| Sex Factors | 1 | 2013 | 10552 | 0.040 |
Why?
|
| Growth Inhibitors | 1 | 2000 | 378 | 0.040 |
Why?
|
| Adiposity | 1 | 2009 | 1878 | 0.040 |
Why?
|
| Cytoskeleton | 1 | 2004 | 1170 | 0.040 |
Why?
|
| Granulocytes | 1 | 2001 | 551 | 0.040 |
Why?
|
| Genes, ras | 1 | 2002 | 654 | 0.040 |
Why?
|
| Sulfites | 2 | 2009 | 83 | 0.040 |
Why?
|
| Insulin | 2 | 2011 | 6596 | 0.040 |
Why?
|
| Multiple Myeloma | 1 | 2016 | 5146 | 0.040 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2020 | 276 | 0.040 |
Why?
|
| Genome-Wide Association Study | 3 | 2013 | 12690 | 0.040 |
Why?
|
| Genetic Variation | 4 | 2011 | 6567 | 0.040 |
Why?
|
| Hepatocyte Growth Factor | 1 | 1999 | 270 | 0.040 |
Why?
|
| Chemokines, CXC | 1 | 1999 | 422 | 0.040 |
Why?
|
| Fluorescence Polarization | 1 | 2018 | 140 | 0.040 |
Why?
|
| Oligodendroglia | 2 | 2012 | 538 | 0.040 |
Why?
|
| Disease Progression | 2 | 2010 | 13506 | 0.040 |
Why?
|
| RNA Stability | 1 | 2020 | 329 | 0.040 |
Why?
|
| Mice, Nude | 2 | 1998 | 3615 | 0.040 |
Why?
|
| Membrane Glycoproteins | 2 | 2010 | 3702 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 1 | 2005 | 1349 | 0.040 |
Why?
|
| Plasmids | 1 | 2003 | 2269 | 0.040 |
Why?
|
| Insulin Resistance | 1 | 2011 | 3963 | 0.040 |
Why?
|
| Lymphokines | 1 | 2000 | 927 | 0.040 |
Why?
|
| Open Reading Frames | 2 | 2011 | 815 | 0.040 |
Why?
|
| Immune Tolerance | 1 | 2006 | 2303 | 0.040 |
Why?
|
| Rabbits | 2 | 2022 | 4772 | 0.040 |
Why?
|
| Niacin | 1 | 2018 | 118 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2005 | 2203 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2007 | 2331 | 0.040 |
Why?
|
| Gene Order | 1 | 2017 | 169 | 0.040 |
Why?
|
| Platelet Function Tests | 1 | 2019 | 271 | 0.030 |
Why?
|
| Cyclin E | 3 | 2002 | 156 | 0.030 |
Why?
|
| Operon | 1 | 1997 | 372 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 13380 | 0.030 |
Why?
|
| Immunization | 1 | 2001 | 1228 | 0.030 |
Why?
|
| Demography | 1 | 2001 | 1648 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2005 | 2455 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2007 | 8631 | 0.030 |
Why?
|
| Politics | 1 | 2003 | 815 | 0.030 |
Why?
|
| Islets of Langerhans | 1 | 2003 | 1341 | 0.030 |
Why?
|
| Bone Marrow Purging | 1 | 1996 | 108 | 0.030 |
Why?
|
| P-Selectin | 1 | 2019 | 597 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2009 | 4063 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2016 | 22176 | 0.030 |
Why?
|
| Embryonal Carcinoma Stem Cells | 1 | 2015 | 20 | 0.030 |
Why?
|
| Genetic Testing | 2 | 2016 | 3537 | 0.030 |
Why?
|
| Estradiol | 1 | 2003 | 1937 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 1999 | 11118 | 0.030 |
Why?
|
| Family Health | 1 | 2001 | 1257 | 0.030 |
Why?
|
| Chromatin Assembly Factor-1 | 1 | 2015 | 21 | 0.030 |
Why?
|
| Gene Frequency | 2 | 2000 | 3606 | 0.030 |
Why?
|
| Biological Availability | 1 | 2016 | 390 | 0.030 |
Why?
|
| Culture Media | 2 | 2012 | 897 | 0.030 |
Why?
|
| Coronary Stenosis | 1 | 2001 | 794 | 0.030 |
Why?
|
| Capacity Building | 1 | 2018 | 258 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2010 | 6391 | 0.030 |
Why?
|
| Proto-Oncogenes | 2 | 1986 | 321 | 0.030 |
Why?
|
| Platelet Aggregation | 1 | 2019 | 771 | 0.030 |
Why?
|
| Colon | 1 | 2023 | 1792 | 0.030 |
Why?
|
| Exons | 2 | 2012 | 2391 | 0.030 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2015 | 68 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2020 | 1561 | 0.030 |
Why?
|
| Platelet Activation | 1 | 2019 | 645 | 0.030 |
Why?
|
| Neural Stem Cells | 2 | 2012 | 888 | 0.030 |
Why?
|
| Immunity | 1 | 2001 | 996 | 0.030 |
Why?
|
| Metabolomics | 2 | 2017 | 1659 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2022 | 26198 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2022 | 1808 | 0.030 |
Why?
|
| Tetraploidy | 1 | 2014 | 28 | 0.030 |
Why?
|
| Age of Onset | 1 | 2001 | 3305 | 0.030 |
Why?
|
| Biological Transport | 2 | 2005 | 2091 | 0.030 |
Why?
|
| Introns | 1 | 2017 | 981 | 0.030 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2015 | 145 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 1996 | 452 | 0.030 |
Why?
|
| DNA Transposable Elements | 1 | 1998 | 755 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2002 | 698 | 0.030 |
Why?
|
| Electroporation | 1 | 2015 | 255 | 0.030 |
Why?
|
| Macaca | 1 | 2015 | 410 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 2015 | 321 | 0.030 |
Why?
|
| Protein Isoforms | 2 | 2014 | 1699 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2005 | 3673 | 0.030 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2014 | 113 | 0.030 |
Why?
|
| Metalloendopeptidases | 1 | 2015 | 393 | 0.030 |
Why?
|
| Adolescent | 1 | 2022 | 88319 | 0.030 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2013 | 49 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2015 | 2865 | 0.030 |
Why?
|
| Carrier Proteins | 3 | 2000 | 4936 | 0.030 |
Why?
|
| RNA Splicing | 2 | 2016 | 918 | 0.030 |
Why?
|
| Myoblasts, Skeletal | 1 | 2013 | 75 | 0.030 |
Why?
|
| RNA, Small Untranslated | 1 | 2013 | 77 | 0.030 |
Why?
|
| Research Design | 1 | 2009 | 6180 | 0.030 |
Why?
|
| Th2 Cells | 1 | 1998 | 1060 | 0.030 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2013 | 123 | 0.030 |
Why?
|
| Histone Demethylases | 1 | 2015 | 320 | 0.030 |
Why?
|
| Myristic Acid | 1 | 1992 | 49 | 0.030 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2013 | 162 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2007 | 10766 | 0.030 |
Why?
|
| Anemia, Sideroblastic | 1 | 2013 | 109 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 934 | 0.030 |
Why?
|
| p21-Activated Kinases | 1 | 2013 | 128 | 0.030 |
Why?
|
| Pancreatic Diseases | 1 | 2014 | 343 | 0.030 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2012 | 65 | 0.030 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2011 | 47 | 0.020 |
Why?
|
| Breast Neoplasms | 3 | 2005 | 21012 | 0.020 |
Why?
|
| Erythropoietin | 1 | 2016 | 719 | 0.020 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2012 | 169 | 0.020 |
Why?
|
| Vulnerable Populations | 1 | 2017 | 703 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2016 | 733 | 0.020 |
Why?
|
| Caspase 2 | 1 | 2011 | 26 | 0.020 |
Why?
|
| Dermis | 1 | 2013 | 202 | 0.020 |
Why?
|
| Medical Oncology | 1 | 2003 | 2321 | 0.020 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2013 | 242 | 0.020 |
Why?
|
| Periodic Acid | 1 | 2011 | 18 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2003 | 3492 | 0.020 |
Why?
|
| Oxidative Stress | 2 | 2013 | 3113 | 0.020 |
Why?
|
| Gliosis | 1 | 2012 | 245 | 0.020 |
Why?
|
| Smad1 Protein | 1 | 2011 | 81 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2003 | 2226 | 0.020 |
Why?
|
| Detergents | 1 | 2012 | 236 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2011 | 127 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2013 | 779 | 0.020 |
Why?
|
| Risk Management | 1 | 2015 | 558 | 0.020 |
Why?
|
| Cell Tracking | 1 | 2012 | 139 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2011 | 184 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2012 | 8181 | 0.020 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2011 | 152 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2015 | 1371 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 1991 | 851 | 0.020 |
Why?
|
| Career Choice | 1 | 2017 | 756 | 0.020 |
Why?
|
| Lovastatin | 1 | 2011 | 115 | 0.020 |
Why?
|
| Phenylbutyrates | 1 | 2011 | 72 | 0.020 |
Why?
|
| Italy | 1 | 2013 | 842 | 0.020 |
Why?
|
| Genes | 3 | 1999 | 1823 | 0.020 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2012 | 247 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2016 | 1076 | 0.020 |
Why?
|
| Iduronidase | 1 | 2010 | 31 | 0.020 |
Why?
|
| Biotinylation | 1 | 2011 | 184 | 0.020 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 2 | 2000 | 138 | 0.020 |
Why?
|
| Chondrogenesis | 1 | 2012 | 239 | 0.020 |
Why?
|
| Transcription Factor DP1 | 2 | 2000 | 136 | 0.020 |
Why?
|
| Bioethics | 1 | 2012 | 117 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2015 | 633 | 0.020 |
Why?
|
| Myosin Heavy Chains | 1 | 2012 | 405 | 0.020 |
Why?
|
| Embryoid Bodies | 1 | 2011 | 65 | 0.020 |
Why?
|
| Leukocytes | 1 | 2019 | 2026 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 1992 | 1085 | 0.020 |
Why?
|
| Mucopolysaccharidosis I | 1 | 2010 | 52 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 1999 | 1858 | 0.020 |
Why?
|
| Solubility | 1 | 2012 | 1091 | 0.020 |
Why?
|
| Stroke | 1 | 2012 | 9757 | 0.020 |
Why?
|
| Centrosome | 1 | 2011 | 209 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 1705 | 0.020 |
Why?
|
| E2F Transcription Factors | 2 | 2000 | 269 | 0.020 |
Why?
|
| Phosphotransferases | 1 | 1991 | 303 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 293 | 0.020 |
Why?
|
| Survival Rate | 2 | 2001 | 12725 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2001 | 4471 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2008 | 1058 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2015 | 856 | 0.020 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2011 | 369 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2011 | 740 | 0.020 |
Why?
|
| Chromosomes, Human, X | 1 | 2012 | 321 | 0.020 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2011 | 393 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 6484 | 0.020 |
Why?
|
| Proteomics | 2 | 2014 | 3849 | 0.020 |
Why?
|
| Vasoconstriction | 1 | 2012 | 592 | 0.020 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2010 | 116 | 0.020 |
Why?
|
| Immunity, Innate | 2 | 2012 | 3065 | 0.020 |
Why?
|
| Catechols | 1 | 2009 | 62 | 0.020 |
Why?
|
| Activins | 1 | 2011 | 210 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2001 | 9646 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2020 | 4159 | 0.020 |
Why?
|
| Pseudogenes | 1 | 2009 | 104 | 0.020 |
Why?
|
| Glycine | 1 | 2012 | 663 | 0.020 |
Why?
|
| Cell Death | 1 | 2014 | 1678 | 0.020 |
Why?
|
| Cyclin D1 | 2 | 2002 | 451 | 0.020 |
Why?
|
| Human Genome Project | 1 | 2009 | 200 | 0.020 |
Why?
|
| Automation | 1 | 2011 | 586 | 0.020 |
Why?
|
| Obesity | 1 | 2011 | 12947 | 0.020 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2012 | 485 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2011 | 1762 | 0.020 |
Why?
|
| GATA1 Transcription Factor | 1 | 2010 | 296 | 0.020 |
Why?
|
| Electroretinography | 1 | 2011 | 525 | 0.020 |
Why?
|
| C-Peptide | 1 | 2011 | 440 | 0.020 |
Why?
|
| Crystallization | 1 | 2010 | 534 | 0.020 |
Why?
|
| Epistasis, Genetic | 1 | 2011 | 352 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 1 | 2012 | 654 | 0.020 |
Why?
|
| Acetylation | 1 | 2011 | 1055 | 0.020 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2009 | 183 | 0.020 |
Why?
|
| Dioxygenases | 1 | 2011 | 345 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2014 | 1893 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 802 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2017 | 1664 | 0.020 |
Why?
|
| Calcineurin | 1 | 2009 | 229 | 0.020 |
Why?
|
| Carcinoma, Embryonal | 1 | 2008 | 37 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2011 | 855 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2011 | 1262 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 789 | 0.020 |
Why?
|
| Middle Aged | 7 | 2020 | 220895 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2011 | 563 | 0.020 |
Why?
|
| Fluorouracil | 1 | 2013 | 1641 | 0.020 |
Why?
|
| Syndrome | 2 | 2008 | 3267 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2009 | 670 | 0.020 |
Why?
|
| Retroviridae Proteins | 1 | 1987 | 94 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 2011 | 617 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2011 | 12148 | 0.020 |
Why?
|
| Neuropeptides | 1 | 2013 | 944 | 0.020 |
Why?
|
| Cloning, Molecular | 4 | 2003 | 4174 | 0.020 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2009 | 330 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2007 | 79 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2011 | 868 | 0.020 |
Why?
|
| Myosin Light Chains | 1 | 2007 | 121 | 0.020 |
Why?
|
| Anemia | 1 | 2016 | 1509 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2011 | 1006 | 0.020 |
Why?
|
| Zinc Fingers | 1 | 2009 | 579 | 0.020 |
Why?
|
| Temperature | 2 | 2005 | 2226 | 0.020 |
Why?
|
| Membrane Transport Proteins | 1 | 2012 | 1035 | 0.020 |
Why?
|
| Gene Products, gag | 1 | 1987 | 312 | 0.020 |
Why?
|
| Vitamin D Deficiency | 1 | 2016 | 1388 | 0.020 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2008 | 368 | 0.020 |
Why?
|
| Body Composition | 1 | 2015 | 2426 | 0.020 |
Why?
|
| Avian Sarcoma Viruses | 1 | 1986 | 76 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2010 | 1596 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2012 | 863 | 0.020 |
Why?
|
| Lysosomes | 1 | 2011 | 924 | 0.020 |
Why?
|
| Ribonuclease III | 1 | 2008 | 279 | 0.020 |
Why?
|
| Gastrula | 1 | 2006 | 82 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1998 | 4217 | 0.020 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2005 | 94 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2012 | 1787 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 1996 | 6814 | 0.020 |
Why?
|
| Fetal Proteins | 1 | 2006 | 98 | 0.020 |
Why?
|
| rho-Associated Kinases | 1 | 2007 | 281 | 0.020 |
Why?
|
| Janus Kinase 2 | 1 | 2008 | 560 | 0.020 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2005 | 186 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2001 | 15266 | 0.020 |
Why?
|
| Annexin A5 | 1 | 2005 | 103 | 0.020 |
Why?
|
| Actins | 1 | 2012 | 2050 | 0.020 |
Why?
|
| Mycoplasma | 1 | 2005 | 147 | 0.010 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2005 | 186 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2009 | 1217 | 0.010 |
Why?
|
| Astrocytes | 1 | 2012 | 1346 | 0.010 |
Why?
|
| Genes, Viral | 1 | 1986 | 649 | 0.010 |
Why?
|
| Deoxyglucose | 1 | 2005 | 333 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2012 | 1878 | 0.010 |
Why?
|
| Thiazolidines | 1 | 2004 | 69 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2011 | 2645 | 0.010 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2004 | 43 | 0.010 |
Why?
|
| Vomiting | 1 | 2007 | 651 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2009 | 3076 | 0.010 |
Why?
|
| beta Catenin | 1 | 2009 | 1040 | 0.010 |
Why?
|
| Anti-HIV Agents | 1 | 1999 | 4527 | 0.010 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2005 | 436 | 0.010 |
Why?
|
| Aged, 80 and over | 3 | 2015 | 58976 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1990 | 2202 | 0.010 |
Why?
|
| Models, Chemical | 1 | 2005 | 611 | 0.010 |
Why?
|
| Methylcellulose | 1 | 2002 | 34 | 0.010 |
Why?
|
| Suspensions | 1 | 2002 | 66 | 0.010 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2004 | 332 | 0.010 |
Why?
|
| Microtubules | 1 | 2008 | 1074 | 0.010 |
Why?
|
| Polyploidy | 1 | 2002 | 119 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2002 | 191 | 0.010 |
Why?
|
| Lasers | 1 | 2005 | 952 | 0.010 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2004 | 507 | 0.010 |
Why?
|
| Genetic Techniques | 1 | 2004 | 427 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2014 | 2781 | 0.010 |
Why?
|
| Heart Failure | 1 | 2005 | 11669 | 0.010 |
Why?
|
| Gelsolin | 1 | 1982 | 189 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 814 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2002 | 360 | 0.010 |
Why?
|
| Epitopes | 1 | 1987 | 2503 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2005 | 1246 | 0.010 |
Why?
|
| E2F2 Transcription Factor | 1 | 2000 | 35 | 0.010 |
Why?
|
| E2F3 Transcription Factor | 1 | 2000 | 36 | 0.010 |
Why?
|
| Diarrhea | 1 | 2007 | 1318 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2008 | 2919 | 0.010 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2000 | 73 | 0.010 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2000 | 96 | 0.010 |
Why?
|
| Aged | 4 | 2020 | 169289 | 0.010 |
Why?
|
| E2F1 Transcription Factor | 1 | 2000 | 178 | 0.010 |
Why?
|
| Leucine Zippers | 1 | 2000 | 116 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 4352 | 0.010 |
Why?
|
| Incidence | 1 | 1999 | 21353 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2012 | 3639 | 0.010 |
Why?
|
| Fatigue | 1 | 2007 | 1552 | 0.010 |
Why?
|
| Child | 2 | 2022 | 80153 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 4414 | 0.010 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2000 | 257 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 4853 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2004 | 1202 | 0.010 |
Why?
|
| Gene Library | 1 | 2002 | 1059 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2013 | 42230 | 0.010 |
Why?
|
| Leukemia, Lymphoid | 1 | 1999 | 310 | 0.010 |
Why?
|
| Cues | 1 | 2004 | 875 | 0.010 |
Why?
|
| COS Cells | 1 | 2000 | 1130 | 0.010 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2005 | 1085 | 0.010 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2000 | 245 | 0.010 |
Why?
|
| Embryo Transfer | 1 | 2002 | 522 | 0.010 |
Why?
|
| Chemokine CXCL12 | 1 | 1999 | 454 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 2000 | 864 | 0.010 |
Why?
|
| Risk Assessment | 1 | 1999 | 23995 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1982 | 1510 | 0.010 |
Why?
|
| Genes, BRCA1 | 1 | 2000 | 764 | 0.010 |
Why?
|
| Bayes Theorem | 1 | 2004 | 2330 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3245 | 0.010 |
Why?
|
| Receptor, erbB-2 | 1 | 2005 | 2557 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2001 | 15500 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 9000 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2008 | 9318 | 0.010 |
Why?
|
| Biological Evolution | 1 | 1999 | 1071 | 0.010 |
Why?
|
| Inflammation | 1 | 2012 | 10773 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 12059 | 0.010 |
Why?
|
| Artificial Intelligence | 1 | 2004 | 2578 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2004 | 5079 | 0.010 |
Why?
|
| Infant | 1 | 2010 | 36192 | 0.000 |
Why?
|
| Chromosomes, Human, 21-22 and Y | 1 | 1986 | 45 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 14666 | 0.000 |
Why?
|
| Chromosomes, Human, 6-12 and X | 1 | 1986 | 69 | 0.000 |
Why?
|
| Immune Sera | 1 | 1986 | 606 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 36426 | 0.000 |
Why?
|
| Brain | 1 | 2011 | 27112 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1986 | 1302 | 0.000 |
Why?
|
| Chickens | 1 | 1986 | 859 | 0.000 |
Why?
|
| Tissue Distribution | 1 | 1986 | 2265 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1991 | 3688 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2007 | 64680 | 0.000 |
Why?
|